10x Genomics (TXG) Operating Margin (2018 - 2025)
Historic Operating Margin for 10x Genomics (TXG) over the last 8 years, with Q4 2025 value amounting to 11.77%.
- 10x Genomics' Operating Margin rose 184300.0% to 11.77% in Q4 2025 from the same period last year, while for Dec 2025 it was 9.49%, marking a year-over-year increase of 223700.0%. This contributed to the annual value of 9.49% for FY2025, which is 223700.0% up from last year.
- Per 10x Genomics' latest filing, its Operating Margin stood at 11.77% for Q4 2025, which was up 184300.0% from 21.64% recorded in Q3 2025.
- In the past 5 years, 10x Genomics' Operating Margin ranged from a high of 17.42% in Q2 2025 and a low of 61.7% during Q3 2023
- Moreover, its 5-year median value for Operating Margin was 27.31% (2024), whereas its average is 26.12%.
- Its Operating Margin has fluctuated over the past 5 years, first surged by 3539600bps in 2021, then plummeted by -461600bps in 2022.
- 10x Genomics' Operating Margin (Quarter) stood at 11.03% in 2021, then plummeted by -34bps to 14.78% in 2022, then tumbled by -103bps to 30.0% in 2023, then fell by -1bps to 30.2% in 2024, then skyrocketed by 61bps to 11.77% in 2025.
- Its Operating Margin stands at 11.77% for Q4 2025, versus 21.64% for Q3 2025 and 17.42% for Q2 2025.